Instituto D'Or de Pesquisa e Ensino - Sao Paulo
Instituto D'Or de Pesquisa e Ensino - Sao Paulo
Av. República do Líbano, 611 - Ibirapuera, São Paulo - SP, 04501-000
Select an option
I am a doctor
I am a sponsor
Open studies
Non-Hodgkin Lymphoma
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma - GLOBRYTE - Hoffmann-La RocheSee more
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma - EPCORE™FL-2 - GenmabSee more
Leukemia
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) - CELESTIAL-RRCLL - BeiGeneSee more
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) - cAMeLot-2 - Janssen Research & Development, LLCSee more
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) - cAMeLot-1 - Janssen Research & Development, LLCSee more
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) - cAMeLot-1 - Janssen Research & Development, LLCSee more
Multiple myeloma
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments - MAGNETISMM-5 - PfizerSee more
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) - MagnetisMM-32 - PfizerSee more
Bladder Cancer
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer - ADVANCED-2 - Protara TherapeuticsSee more
Endometrial Cancer
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer - Fern-EC-01 - BioNTech SESee more
Breast Cancer
TIL-Driven De-escalated Chemotherapy in Stage I-II TNBC - DespaTIL - D'Or Institute for Research and EducationSee more
Lymphoma
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
Rare diseases
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
Prostate cancer
A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer - Darolutamide - D'Or Institute for Research and EducationSee more
Colorectal cancer
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation - CodeBreaK 301 - AmgenSee more
